Insider Transactions in Q4 2020 at Trans Medics Group, Inc. (TMDX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,816
-47.47%
|
$176,320
$20.0 P/Share
|
|
Dec 21
2020
|
John F Sullivan VP of Quality & Engineering |
SELL
Open market or private sale
|
Direct |
1,000
-8.45%
|
$17,000
$17.99 P/Share
|
|
Dec 16
2020
|
John F Sullivan VP of Quality & Engineering |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+7.8%
|
$0
$0.39 P/Share
|
|
Dec 15
2020
|
John F Sullivan VP of Quality & Engineering |
SELL
Open market or private sale
|
Direct |
3,000
-21.7%
|
$48,000
$16.63 P/Share
|
|
Dec 15
2020
|
John F Sullivan VP of Quality & Engineering |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+17.83%
|
$0
$0.39 P/Share
|
|
Dec 11
2020
|
Miriam Provost VP, Global Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+50.0%
|
$13,800
$3.22 P/Share
|